(-)-Epigallocatechin-3-gallate Ameliorates Intervertebral Disc Degeneration Through Reprogramming of the Circadian Clock

(-)-Epigallocatechin-3-gallate Ameliorates Intervertebral Disc Degeneration Through Reprogramming of the Circadian Clock

The circadian clock is vital in the management of our daily physiological as well as metabolic processes. Disturbances of the clock can cause degenerative and age-related diseases. Increasing evidence has indicated that the intervertebral discs contain an internal biological clock related to degener...

Full description

Bibliographic Details
Main Authors:	Liangwei Mei, Yi Zheng, Teng Ma, Bing Xia, Xue Gao, Yiming Hao, Zhuojing Luo, Jinghui Huang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-11-01
Series:	Frontiers in Pharmacology
Subjects:	circadian clock intervertebral disc degeneration (IDD) (-)-epigallocatechin-3-gallate (EGCG) oxidative stress Bmal1
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2021.753548/full

Similar Items

Antioxidant and antiviral activities of lipophilic epigallocatechin gallate (EGCG) derivatives
by: Ying Zhong, et al.
Published: (2012-01-01)

Protective Effect of Liposomal Epigallocatechin-Gallate in Experimental Gentamicin-Induced Hepatotoxicity
by: Adriana Elena Bulboacă, et al.
Published: (2022-02-01)

Synthesis and Biological Testing of Novel Glucosylated Epigallocatechin Gallate (EGCG) Derivatives
by: Xin Zhang, et al.
Published: (2016-05-01)

Targeting clock-controlled gene Nrf2 ameliorates inflammation-induced intervertebral disc degeneration
by: Pandi Peng, et al.
Published: (2022-08-01)

Y6, an Epigallocatechin Gallate Derivative, Reverses ABCG2-Mediated Mitoxantrone Resistance
by: Rui-Qiang Zhao, et al.
Published: (2019-01-01)

Efficacy of topical hydrogel Epigallocatechin-3-gallate against neutrophil cells in perforated dental pulp
by: Kun Ismiyatin, et al.
Published: (2020-06-01)

Assessing the Hepatic Safety of Epigallocatechin Gallate (EGCG) in Reproductive-Aged Women
by: Hiba Siblini, et al.
Published: (2023-01-01)

Epigallocatechin gallate (EGCG) attenuates myocardial hypertrophy and fibrosis induced by transverse aortic constriction via inhibiting the Akt/mTOR pathway
by: Yue Cui, et al.
Published: (2021-01-01)

Epigallocatechin-3-Gallate Alleviates Liver Oxidative Damage Caused by Iron Overload in Mice through Inhibiting Ferroptosis
by: Chunjing Yang, et al.
Published: (2023-04-01)

The Potential Roles of Epigallocatechin-3-Gallate in the Treatment of Ovarian Cancer: Current State of Knowledge
by: Bimonte S, et al.
Published: (2020-10-01)

Uterine fibroid treatment with Vitamin D combined with Epigallocatechin gallate and Vitamin B6: a controlled pilot study
by: G. Porcaro, et al.
Published: (2021-03-01)

Topical Epigallocatechin Gallate (EGCG) 1% for Chronic Plantar Ulcers in Leprosy
by: Riyana Noor Oktaviyanti, et al.
Published: (2020-07-01)

Preclinical Activities of Epigallocatechin Gallate in Signaling Pathways in Cancer
by: Mehdi Sharifi-Rad, et al.
Published: (2020-01-01)

Influence of Exogenous Epigallocatechin Gallate Addition on Physicochemical Properties of Buckwheat Flour and Eating Quality of Buckwheat Wantuo
by: Di WU, et al.
Published: (2023-01-01)

(-)-Epigallocatechin-3-Gallate Inhibits Arsenic-Induced Inflammation and Apoptosis through Suppression of Oxidative Stress in Mice
by: Nan-Hui Yu, et al.
Published: (2017-04-01)

Targeting Cancer Hallmarks with Epigallocatechin Gallate (EGCG): Mechanistic Basis and Therapeutic Targets
by: Wamidh H. Talib, et al.
Published: (2024-03-01)

Epigallocatechin Gallate for the Treatment of Benign and Malignant Gynecological Diseases—Focus on Epigenetic Mechanisms
by: Marta Włodarczyk, et al.
Published: (2024-02-01)

The Importance of Epigallocatechin as a Scaffold for Drug Development against Flaviviruses
by: Mônika A. Coronado, et al.
Published: (2023-03-01)

Food-Grade Microencapsulation Systems to Improve Protection of the Epigallocatechin Gallate
by: Mathis Ralaivao, et al.
Published: (2022-07-01)

Effect of epigallocatechin gallate on the fermentative and physicochemical properties of fermented milk
by: Xiaoqian Chen, et al.
Published: (2022-09-01)

Reduction of photodynamic damage of blood vessels in the protected region by (–)-epigallocatechin gallate
by: Tianlong Chen, et al.
Published: (2024-05-01)

Bioavailability of Epigallocatechin Gallate Administered with Different Nutritional Strategies in Healthy Volunteers
by: Vicente Andreu Fernández, et al.
Published: (2020-05-01)

Amelioration of cisplatin sensitivity in human cervical cancer: Epigallocatechin-3-Gallate
by: Ulkan eKilic, et al.
Published: (2015-01-01)

Targeting Glycolysis with Epigallocatechin-3-Gallate Enhances the Efficacy of Chemotherapeutics in Pancreatic Cancer Cells and Xenografts
by: Ran Wei, et al.
Published: (2019-10-01)

(–)-Epigallocatechin-3-Gallate Protects Human Skin Fibroblasts from Ultraviolet a Induced Photoaging
by: Jia Y, et al.
Published: (2023-01-01)

Effect of Guava Powder Addition on Epigallocatechin Gallate (EGCG) Content of Green Tea and Its Antioxidant Activity
by: Hanifah Ridha Rabbani, et al.
Published: (2020-03-01)

Research on the Interaction between Epigallocatechin Gallate and Millet Bran Protein
by: MIAO Xiang-shuo, et al.
Published: (2022-09-01)

Major roles of the circadian clock in cancer
by: Chen Huang, et al.
Published: (2023-01-01)

Autophagy or Apoptosis: Anticancer Molecular Mechanism of Epigallocatechin Gallate with Natural Polyphenol Effect on HepG2 Cells Viability
by: Rand R. Hafidh, et al.
Published: (2023-06-01)

Therapeutic effects of epigallocatechin and epigallocatechin gallate on the allergic reaction of αs1-casein sensitized mice
by: Qianqian Zhang, et al.
Published: (2023-05-01)

Epigallocatechin Gallate for Management of Heavy Metal-Induced Oxidative Stress: Mechanisms of Action, Efficacy, and Concerns
by: Iwona Zwolak
Published: (2021-04-01)

Epigallocatechin-3-Gallate (EGCG), an Active Compound of Green Tea Attenuates Acute Lung Injury Regulating Macrophage Polarization and Krüpple-Like-Factor 4 (KLF4) Expression
by: Saleh A. Almatroodi, et al.
Published: (2020-06-01)

Efficacy of topical epigallocatechin gallate (EGCG) 1% on the healing of chronic plantar ulcers in leprosy
by: C. R. S. Prakoeswa, et al.
Published: (2021-11-01)

Epigallocatechin-3-Gallate Protects H2O2-Induced Nucleus Pulposus Cell Apoptosis and Inflammation by Inhibiting cGAS/Sting/NLRP3 Activation
by: Tian Y, et al.
Published: (2020-05-01)

Intra-Articular Injection of (−)-Epigallocatechin 3-Gallate (EGCG) Ameliorates Cartilage Degeneration in Guinea Pigs with Spontaneous Osteoarthritis
by: Hsuan-Ti Huang, et al.
Published: (2021-01-01)

(−)-Epigallocatechin-3-Gallate Inhibits the Life Cycle of Pseudorabies Virus In Vitro and Protects Mice Against Fatal Infection
by: Changchao Huan, et al.
Published: (2021-01-01)

Epigallocatechin-3-Gallate (EGCG): New Therapeutic Perspectives for Neuroprotection, Aging, and Neuroinflammation for the Modern Age
by: Ashley Payne, et al.
Published: (2022-02-01)

The roles of epigallocatechin gallate in the tumor microenvironment, metabolic reprogramming, and immunotherapy
by: Dongming Li, et al.
Published: (2024-01-01)

Involvement of MicroRNA-296 in the Inhibitory Effect of Epigallocatechin Gallate against the Migratory Properties of Anoikis-Resistant Nasopharyngeal Carcinoma Cells
by: Chien-Hung Lin, et al.
Published: (2020-04-01)

Protective Effects of Epigallocatechin-3-gallate (EGCG) against the Jellyfish <i>Nemopilema nomurai</i> Envenoming
by: Jie Li, et al.
Published: (2023-04-01)